Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News



Format: 04/16/2014
Format: 04/16/2014


Pittsburgh Post-Gazette: FDA's approval of Pradaxa has given patients another choice for treating A-fib

Monday, August 1st, 2011

A new anticoagulant, Pradaxa, may be useful in treating patients with A-fib. West Penn Allegheny cardiologists and hematologists weigh in on the benefits and limitations of Pradaxa and the more established alternative, Coumadin.

To read more, visit the Post-Gazette web site.

West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 7 + 2 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.